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Purpose
The addition of MRI to mammography and ultrasound for
breast cancer screening has been shown to improve
screening sensitivity in high risk women (i.e., those with a
BRCA mutation). Here we evaluate the addition of MRI to
conventional screening (ultrasound and mammography)
for women at average or intermediate risk of cancer.
Patients and Methods
From 2008 to 2011, 2995 women, aged 40 to 65 years with
no previous history of breast cancer were enrolled in a
prospective screening trial consisting of two annual rounds
of MRI, ultrasound and mammography. 356 women had a
CHEK2 mutation, 458 women had a first-degree relative
with breast cancer and 2269 women had neither risk fac-
tor. Subjects were followed for incident cancer for one
year from the date of the second screening examination.
Results
In this cohort of 2995 women, 21 invasive epithelial can-
cers, one angiosarcoma and four cases of DCIS were
identified over a two-year period. Of the invasive cancers,
20 were screen-detected and one was an interval cancer.
Of the 21 invasive cancers detected in the cohort, 14
(67%) were less than 2 cm and 16 (76%) were node-nega-
tive. The sensitivity of MRI was 90%, the sensitivity of
ultrasound was 62% and the sensitivity of mammography
was 57%. The number of biopsies incurred by MRI (156)
was far greater than the number incurred by either
mammography (n = 35) or by ultrasound (n = 57). No
cancer was identified by mammography that was not also
identified by MRI, but one cancer was detected by ultra-
sound that was missed by MRI. Of the 19 cancers that
were detected by MRI, 17 were also detected by ultra-
sound or mammography and two were detected by MRI
alone.
Conclusion
In terms of sensitivity, MRI is superior or similar to the
combination of mammography and ultrasound for
screening of women at low or intermediate risk of breast
cancer. However, because of the additional costs incurred
and the number of biopsies required in order to detect a
few additional breast cancers, MRI screening is probably
not warranted outside of high-risk populations.
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